Journal of the American Heart Association

MARCH 3, 2025

Atrial fibrillation (AF) is the most common sustained arrhythmia and associated with increased morbidity and mortality. We performed a systematic review investigating the effect of rurality on AF care and outcomes in the United States. Journal of the American Heart Association, Ahead of Print.

Atrial Fibrillation 40

Atrial Fibrillation Atrial Flutter Outcomes Article 40

Journal of Cardiovascular Pharmacology

NOVEMBER 11, 2024

Intravenous (IV) digoxin loading dose recommendations for rate control of atrial arrhythmias in critically ill patients are not well studied. Secondary outcomes included the frequency of SDCs ≥1.5 Secondary outcomes included the frequency of SDCs ≥1.5 ng/mL is recommended. ng/mL and heart rate (HR) control. ng/mL is recommended.

Arrhythmia 40

Arrhythmia Atrial Flutter Atrial Fibrillation Outcomes 40

Cardiomatics

APRIL 5, 2024

By understanding the nuances of abnormalities detected in Cardiomatics and interpreting detailed reports, healthcare professionals can intervene promptly to prevent adverse outcomes. AFIB/AFL – atrial fibrillation or atrial flutter episodes. AV blocks – 2nd degree and 3rd degree atrioventricular blocks.

Arrhythmia 92

Arrhythmia Tachycardia Bradycardia Electrocardiogram 92

Physiologically Speaking

JULY 26, 2024

A nightly sleep duration less than 6 hours per night appears to be especially detrimental, but some studies have even shown worse health outcomes for adults sleeping 7 hours or less compared to those sleeping the recommended 7–9 hours per night. The impact of optimizing circadian biology on health cannot be understated.

Chronic Disease 64

Chronic Disease Physiology Atrial Flutter Atrial Fibrillation 64

CardiacWire

DECEMBER 3, 2023

In this Cardiac Wire Q&A, we sat down with AccurKardia CEO Juan C Jimenez and COO Mohamed Sadeq Ali to discuss ECG automation’s massive potential to improve clinical efficiency and care outcomes. This gives doctors their ECG reports faster, so they can start treatments earlier, and improve patient outcomes.

Arrhythmia 52

Arrhythmia Atrial Flutter Reimbursement Atrial Fibrillation 52

Dr. Smith's ECG Blog

AUGUST 23, 2017

It is atrial flutter with 2:1 conduction. There are clear flutter waves in lead II across the bottom. In V1, there are upright waves that appear to be P-waves but are not: they are atrial waves and it is typical for atrial flutter waves to be upright in V1, whereas sinus P-waves are biphasic in V1.

Atrial Flutter 52

Atrial Flutter Tachycardia Atrial Fibrillation Article 52

DAIC

MARCH 5, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). Atrial Fibrillation. Circulation.

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59

Dr. Smith's ECG Blog

NOVEMBER 26, 2018

The rhythm differential for narrow, regular, and tachycardic is sinus rhythm, SVT (encompassing AVNRT, AVRT, atrial tach, etc), and atrial flutter (another supraventricular rhythm which is usually considered separately from SVTs). Therefore this patient is either in some form of SVT or atrial flutter. If so, why?

Ischemia 52

Ischemia Atrial Flutter Arrhythmia Tachycardia 52

Journal of Cardiovascular Electrophysiology

NOVEMBER 5, 2024

We hypothesised that short-term bleeding outcomes using the Fo8 MOD approach would be superior to MC. We additionally compared outcomes between Fo8 MOD and Fo8 HT approaches. Procedures were most commonly for atrial fibrillation (52.4%), atrial flutter (10.9%), and atrioventricular nodal re-entrant tachycardia (10.1%).

Electrophysiology 40

Electrophysiology Atrial Flutter Atrial Fibrillation Tachycardia 40

Journal of Cardiovascular Electrophysiology

DECEMBER 17, 2024

Abstract Background Dofetilide is a class III antiarrhythmic agent approved for the treatment of atrial fibrillation and atrial flutter. The composite outcome of VT/VF recurrence, heart transplantation, or death occurred in 6/12 patients (50%) without dofetilide and 49/69 patients (71%) with dofetilide.

Tachycardia 40

Tachycardia Heart Disease Atrial Flutter Heart Transplant 40

Cardiovascular Diabetology

FEBRUARY 23, 2024

The effects of SGLT2i on atrial fibrillation(AF), atrial flutter(AFL), composite AF/AFL, ventricular fibrillation(VF), ventricular tachycardia(VT), ventricular extrasystoles(VES), sudden cardiac death(SCD) and composite VF/VT/SCD were evaluated. RCTs comparing SGLT2i with placebo were included.

Sudden Cardiac Death 64

Sudden Cardiac Death Arrhythmia Atrial Flutter Heart Failure 64

Dr. Smith's ECG Blog

APRIL 8, 2015

Cardiac Syncope ("True Syncope") Independent Predictors of Adverse Outcomes condensed from multiple studies 1. These premonitory symptoms were negative predictors of adverse outcomes in EGSYS. Abnormal ECG – looks for cardiac syncope. Hemoglobin less than 10 (SF rule) 6. Syncope with Exertion (EGSYS) 7. S yncope while supine (EGSYS) 8.

Arrhythmia 52

Arrhythmia Outcomes Chest Pain Risk Factors 52

DAIC

OCTOBER 30, 2024

The Sphere-9 catheter enhances workflow efficiency for physicians while providing excellent safety and efficacy outcomes. We will continue to fulfill our commitment to innovation, including new indications, to advance cardiovascular care and improve patient outcomes." tim.hodson Wed, 10/30/2024 - 13:42 Oct.

Ablation 52

Ablation AFIB Atrial Fibrillation Atrial Flutter 52

Journal of Cardiovascular Electrophysiology

JANUARY 7, 2025

ABSTRACT Typical atrial flutter (AFL), defined as cavotricuspid isthmus (CTI)-dependent macro-re-entrant atrial tachycardia, often causes debilitating symptoms, and is associated with increased incidence of atrial fibrillation, stroke, heart failure, and death.

Atrial Flutter 45

Atrial Flutter Atrial Fibrillation Quality of Life Ablation 45